MedTrace Logo

Effect of Azithromycin in Preventing Premature Labour

NCT05465304 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2023-05-17

No results posted yet for this study

Summary

This is a prospective observational case controlled study. The control group will include pregnant women, having intact membranes and are at risk of or in preterm labour, administrating the standard treatments for prolongation of pregnancy.

The test group will involve pregnant women, having intact membranes and are at risk of or in preterm labour, administrating the standard treatments for prolongation of pregnancy plus azithromycin

Conditions

  • Pregnant With Complication

Interventions

DRUG

Azithromycin

The assessment of efficacy of azithromycin in preventing premature labour.The duration between administrating azithromycin as monotherapy and polytherapy and labour is calculated

Sponsors & Collaborators

  • Beni-Suef University

    lead OTHER

Principal Investigators

  • Raghda R.S Hussein · Beni-Suef University

Eligibility

Min Age
18 Years
Max Age
32 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-01
Primary Completion
2022-04-01
Completion
2022-04-30
FDA Drug
Yes

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05465304 on ClinicalTrials.gov